BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3275897)

  • 1. Aspirin for the primary prevention of myocardial infarction.
    Relman AS
    N Engl J Med; 1988 Jan; 318(4):245-6. PubMed ID: 3275897
    [No Abstract]   [Full Text] [Related]  

  • 2. [Various observations on the results of the "Aspirin myocardial infarction study" and the "Persantine-aspirin reinfarction study" in the United States].
    Lubsen J
    Ned Tijdschr Geneeskd; 1981 Oct; 125(40):1606-9. PubMed ID: 7029311
    [No Abstract]   [Full Text] [Related]  

  • 3. Three large-scale clinical trials of aspirin in the USA.
    Krol WF
    Proc R Soc Med; 1977; 70 Suppl 7(Suppl 7):24-7. PubMed ID: 353816
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin and myocardial infarction.
    Drug Ther Bull; 1987 Mar; 25(5):17-9. PubMed ID: 3545741
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of pharmacotherapy in secondary prevention of myocardial infarction and death.
    Gorlin R; Fuster V
    Mt Sinai J Med; 1984 Jun; 51(3):229-36. PubMed ID: 6146929
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin and the prevention of stroke after transient ischaemic attack.
    Warlow C
    Monogr Atheroscler; 1986; 14():203-6. PubMed ID: 3526126
    [No Abstract]   [Full Text] [Related]  

  • 7. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
    N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled trial of aspirin in the prevention of early mortality in myocardial infarction.
    Elwood PC; Williams WO
    J R Coll Gen Pract; 1979 Jul; 29(204):413-6. PubMed ID: 392079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of prevention of second myocardial infarct with syncumar or aspirin].
    Kraska T; Malanowicz W; Skarzyńska M; Tymińska K
    Kardiol Pol; 1981; 24(9):593-7. PubMed ID: 7029110
    [No Abstract]   [Full Text] [Related]  

  • 10. Secondary prevention of myocardial infarction. Comparison of acetylsalicylic acid, phenprocoumon and placebo. A multicenter two-year prospective study.
    Breddin K; Loew D; Lechner K; Uberla K; Walter E
    Thromb Haemost; 1979 Feb; 41(1):225-36. PubMed ID: 483232
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aspirin and heart infarct: one proof is no proof].
    Verheugt FW
    Ned Tijdschr Geneeskd; 1988 Apr; 132(14):614-7. PubMed ID: 3362235
    [No Abstract]   [Full Text] [Related]  

  • 12. [After the disappointing ASS primary prevention trial. "Holding back in women"].
    Rupprecht HJ
    MMW Fortschr Med; 2005 Mar; 147(12):13. PubMed ID: 15832783
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trials of platelet-active drugs in coronary heart disease: summary of design features.
    Furberg CD; May GS
    Circulation; 1980 Dec; 62(6 Pt 2):V49-52. PubMed ID: 7002352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the results of using aspirin in preventing recurrence of myocardial infarct].
    Halawa B; Mazurek W
    Wiad Lek; 1981 Oct; 34(19):1621-6. PubMed ID: 7039141
    [No Abstract]   [Full Text] [Related]  

  • 15. Can aspirin prevent recurrence of heart attacks and strokes?
    Kent S
    Geriatrics; 1982 Jan; 37(1):169-72. PubMed ID: 7033047
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized comparative trial of triflusal and aspirin following acute myocardial infarction.
    Cruz-Fernández JM; López-Bescós L; García-Dorado D; López García-Aranda V; Cabadés A; Martín-Jadraque L; Velasco JA; Castro-Beiras A; Torres F; Marfil F; Navarro E
    Eur Heart J; 2000 Mar; 21(6):457-65. PubMed ID: 10681486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
    Breddin K; Loew D; Lechner K; Oberla K; Walter E
    Circulation; 1980 Dec; 62(6 Pt 2):V63-72. PubMed ID: 6777073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Less myocardial infarcts with Colfarit--a new double blind study].
    Med Monatsschr; 1977 Sep; 31(9):389-90. PubMed ID: 333259
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin for primary prevention. Doctors and patients should understand potential benefits and risks of aspirin treatment.
    Alkhenizan A
    BMJ; 2000 Dec; 321(7274):1472-3. PubMed ID: 11187951
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
    Klimt CR; Doub PH; Doub NH
    Thromb Haemost; 1976 Feb; 35(1):49-56. PubMed ID: 785688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.